Skip to content

Elastography and Treatment of Lymphoma

The Role of Sonoelastography in Evaluation of Therapeutic Response in Patients With Lymphoma.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05967975
Enrollment
44
Registered
2023-08-01
Start date
2023-08-31
Completion date
2025-12-31
Last updated
2023-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elastography, Lymphoma

Brief summary

To determine accuracy of elastography in assessment of superficial lymph nodes response to treatment in cases of lymphoma.

Detailed description

Lymphomas are a heterogeneous group of malignancies that arise from the clonal proliferation of lymphocytes. It represents approximately 5% of malignancies. Overall survival is estimated to be 72%. (1) Lymphomas are broadly classified into Hodgkin lymphoma (HL) (10%) and Non-Hodgkin lymphoma (NHL) (90%). HL is further classified into classical and non-classical types and NHL into B-cell, T-cell and natural killer (NK) cell types. Diagnosis of lymphoma is confirmed by histopathology (FNAC, True-cut or excisional biopsy).(2) The standard treatment of lymphoma is chemotherapy and radiotherapy. The modalities used for staging and follow up of lymphoma are: * Computed Tomography (CT) chest, abdomen and pelvis. * Positron Emission Tomography (PET/CT). * Whole body Magnetic Resonance Imaging (MRI).(3) Sonoelastography is a new technique that depends on the elastic properties of soft tissues, with the idea of malignant lesions being stiffer than benign or normal tissue. It may have a dependable role in evaluation of therapeutic response in patients with lymphoma and can be used for follow up, the same way it has been used in different parts of the body, such as the breast, and thyroid. To the best of our knowledge, there are few studies concerning the role of elastography in the field of lymphoma disease.(4)

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients who are histopathologically proven as lymphoma, not receive treatment and have superficial lymphadenopathy.

Exclusion criteria

* 1-Lymphoma without superficial lymph nodes. 2-patients under treatment.

Design outcomes

Primary

MeasureTime frameDescription
To determine accuracy of elastography in assessment of superficial lymph nodes response to treatment in cases of lymphoma.Average three yearsSonoelastography is a new technique that depends on the elastic properties of soft tissues, with the idea of malignant lesions being stiffer than benign or normal tissue. It may have a dependable role in evaluation of therapeutic response in patients with lymphoma and can be used for follow up, the same way it has been used in different parts of the body, such as the breast, and thyroid. To the best of our knowledge, there are few studies concerning the role of elastography in the field of lymphoma disease.

Contacts

Primary ContactKero Refaat, Resident
kerolsrefaat13@gmail.com+2 01110134427

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026